InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,823.52
(
0.27%
)
US TECH 100
19,831.20
(
0.09%
)
Dow Jones
42,387.57
(
0.65%
)
Brent Oil
71.66
(
-1.38%
)
Bitcoin
69,666.69
(
2.57%
)
Post# of 5074
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PoemStone

Send PM Follow Ignore
Followers 863
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

PoemStone

Re: PoemStone post# 4793

Monday, 09/10/2012 4:49:06 PM

Monday, September 10, 2012 4:49:06 PM

Post# of 5074
PPHM. Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2013 Financial Results and Recent Developments
Interim Data Show Doubling of Median Overall Survival in Bavituximab-Treated Patients from Double-Blind, Placebo-Controlled Phase II Trial in Second-Line Non-Small Cell Lung Cancer; Recent Data Strongly Support Advancing Bavituximab Program Into Phase III Clinical Development
http://finance.yahoo.com/news/peregrine-pharmaceuticals-reports-first-quarter-130611753.html

http://stockcharts.com/c-sc/sc?s=PPHM&p=D&yr=0&mn=4&dy=0&i=t43471744651&r=1347309948085

The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up